159 related articles for article (PubMed ID: 16197294)
1. Hyperhomocysteinemia and macromolecule modifications in uremic patients.
Perna AF; Capasso R; Lombardi C; Acanfora F; Satta E; Ingrosso D
Clin Chem Lab Med; 2005; 43(10):1032-8. PubMed ID: 16197294
[TBL] [Abstract][Full Text] [Related]
2. Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism.
Perna AF; Castaldo P; De Santo NG; di Carlo E; Cimmino A; Galletti P; Zappia V; Ingrosso D
Kidney Int; 2001 Jun; 59(6):2299-308. PubMed ID: 11380834
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine in uremia.
Perna AF; Ingrosso D; Lombardi C; Cesare CM; Acantora F; Satta E; De Santo NG
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S123-6. PubMed ID: 12612968
[TBL] [Abstract][Full Text] [Related]
4. Metabolic consequences of hyperhomocysteinemia in uremia.
Perna AF; Ingrosso D; Satta E; Romano M; Cimmino A; Galletti P; Zappia V; De Santo NG
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S85-90. PubMed ID: 11576929
[TBL] [Abstract][Full Text] [Related]
5. Possible mechanisms of homocysteine toxicity.
Perna AF; Ingrosso D; Lombardi C; Acanfora F; Satta E; Cesare CM; Violetti E; Romano MM; De Santo NG
Kidney Int Suppl; 2003 May; (84):S137-40. PubMed ID: 12694330
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit.
Perna AF; Ingrosso D; Violetti E; Luciano MG; Sepe I; Lanza D; Capasso R; Ascione E; Raiola I; Lombardi C; Stenvinkel P; Massy Z; De Santo NG
Semin Dial; 2009; 22(4):351-6. PubMed ID: 19708980
[TBL] [Abstract][Full Text] [Related]
7. [Hyperhomocysteinemia in chronic renal failure.].
Satta E; Perna AF; Lombardi C; Acanfora F; Violetti E; Romano MM; Capasso R; Pisano M; Paduano F; De Santo NG
G Ital Nefrol; 2006; 23(5):480-9. PubMed ID: 17123261
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of hyperhomocysteinemia and their management by folic acid.
Perna AF; De Santo NG; Ingrosso D
Miner Electrolyte Metab; 1997; 23(3-6):174-8. PubMed ID: 9387111
[TBL] [Abstract][Full Text] [Related]
9. Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: cardiovascular and metabolic consequences.
Perna AF; Capasso R; Acanfora F; Satta E; Lombardi C; Ingrosso D; Violetti E; Romano MM; De Santo NG
Semin Nephrol; 2006 Jan; 26(1):20-3. PubMed ID: 16412820
[TBL] [Abstract][Full Text] [Related]
10. The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin.
Perna AF; Zacchia M; Trepiccione F; Ingrosso D
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28075397
[TBL] [Abstract][Full Text] [Related]
11. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
[TBL] [Abstract][Full Text] [Related]
12. Epigenetics in hyperhomocysteinemic states. A special focus on uremia.
Ingrosso D; Perna AF
Biochim Biophys Acta; 2009 Sep; 1790(9):892-9. PubMed ID: 19245874
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients--Italian initiative on uremic hyperhomocysteinemia (IIUH).
Perna AF; Ingrosso D; Molino D; Galletti P; Montini G; Zacchello G; Bellantuono R; Caringella A; Fede C; Chimenz R; De Santo NG
J Nephrol; 2003; 16(4):516-21. PubMed ID: 14696753
[TBL] [Abstract][Full Text] [Related]
14. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.
Ingrosso D; Cimmino A; Perna AF; Masella L; De Santo NG; De Bonis ML; Vacca M; D'Esposito M; D'Urso M; Galletti P; Zappia V
Lancet; 2003 May; 361(9370):1693-9. PubMed ID: 12767735
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin.
Perna AF; Castaldo P; Ingrosso D; De Santo NG
J Nephrol; 1999; 12(4):230-40. PubMed ID: 10493566
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine and transmethylations in uremia.
Perna AF; Ingrosso D; Castaldo P; Galletti P; De Santo NG
Kidney Int Suppl; 2001 Feb; 78():S230-3. PubMed ID: 11169016
[TBL] [Abstract][Full Text] [Related]
17. Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia.
Perna AF; Ingrosso D; De Santo NG; Galletti P; Brunone M; Zappia V
J Am Soc Nephrol; 1997 Dec; 8(12):1899-905. PubMed ID: 9402092
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine metabolism in renal failure.
Perna AF; Ingrosso D; Satta E; Lombardi C; Acanfora F; De Santo NG
Curr Opin Clin Nutr Metab Care; 2004 Jan; 7(1):53-7. PubMed ID: 15090904
[TBL] [Abstract][Full Text] [Related]
19. Plasma protein homocysteinylation in uremia.
Perna AF; Acanfora F; Luciano MG; Pulzella P; Capasso R; Satta E; Cinzia L; Pollastro RM; Iannelli S; Ingrosso D; De Santo NG
Clin Chem Lab Med; 2007; 45(12):1678-82. PubMed ID: 17937608
[TBL] [Abstract][Full Text] [Related]
20. Is homocysteine toxic in uremia?
Perna AF; Luciano MG; Pulzella P; Satta E; Capasso R; Lombardi C; Ingrosso D; De Santo NG
J Ren Nutr; 2008 Jan; 18(1):12-7. PubMed ID: 18089438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
